Arctic Bioscience AS Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	42.62	44.4	33.76	34.47	21.52
Revenue Growth	-4.01%	31.55%	-2.07%	60.21%	4.48%
Cost of Revenue	29.05	31.6	23.98	22.63	16.36
Gross Profit	13.57	12.81	9.78	11.84	5.16
Selling, General & Admin	24.41	25.95	23.51	24.36	17.26
Depreciation & Amortization Expenses	5.12	5.15	5.38	3.73	2.52
Other Operating Expenses	17.48	29.5	29.47	21.15	25.96
Total Operating Expenses	47.01	60.6	58.37	49.23	45.74
Operating Income	-33.45	-47.79	-48.59	-37.39	-40.58
Total Non-Operating Income (Expense)	-7.58	-0.14	3.07	3.36	-2
Pretax Income	-41.03	-47.93	-45.51	-34.02	-42.58
Net Income	-41.03	-47.93	-45.51	-34.02	-42.58
Net Income to Common	-41.03	-47.93	-45.51	-34.02	-42.58
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	31	25	25	24	24
Shares Outstanding (Diluted)	31	25	25	24	24
Shares Change	22.55%	-0.26%	3.88%	0.60%	88.48%
EPS (Basic)	-1.32	-1.89	-1.79	-1.39	-1.75
EPS (Diluted)	-1.32	-1.89	-1.79	-1.39	-1.75
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-45.4	-94.17	-65.07	-83.96	-76
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Per Share	-1.46	-3.71	-2.56	-3.43	-3.12
Gross Margin	31.84%	28.84%	28.97%	34.36%	23.98%
Operating Margin	-78.47%	-107.63%	-143.93%	-108.47%	-188.60%
Profit Margin	-96.25%	-107.95%	-134.83%	-98.71%	-197.90%
FCF Margin	-106.52%	-212.07%	-192.78%	-243.58%	-353.22%
EBITDA	-28.33	-42.64	-43.2	-33.66	-38.06
EBITDA Margin	-66.46%	-96.02%	-127.99%	-97.65%	-176.90%
EBIT	-33.45	-47.79	-48.59	-37.39	-40.58
EBIT Margin	-78.47%	-107.63%	-143.93%	-108.47%	-188.60%